Event Details
- Date of Announcement: July 16, 2026
- Event: Launch of AI-powered Signature Lab in South Delhi
- This represents the first milestone in the company's planned 19-center expansion roadmap as outlined during its IPO
Facility Features
The new South Delhi center includes:
- Gaudium Signature Lab - proprietary laboratory framework integrating advanced embryology and AI-powered technologies
- AI-powered embryology ecosystem including:
- SiD (Sperm Identification Device) for advanced sperm assessment
- ERICA (Embryo Ranking Intelligent Classification Assistant) for embryo evaluation
- Comprehensive fertility care under one roof with standardized clinical protocols
- Strategically located in South Delhi
Expansion Strategy
The Signature Lab model will be replicated across all 19 planned new centers to ensure:
- Consistent high standards of precision, safety, and clinical excellence
- Same patient experience regardless of location
- Standardized clinical and laboratory model combining AI innovation with clinical excellence
Company Background
- Founded in 2009 (17 years of fertility expertise)
- India's first publicly listed IVF chain
- PAN India presence with growing global reach
- Internationally recognized with European Quality Award from ESQR, Spain
- Specializes in complex infertility and recurrent IVF failure cases
Management Commentary
Dr. Manika Khanna, Chairperson and Managing Director, stated: "The launch reflects our commitment to making world-class fertility care more accessible without compromising on standards. Our focus remains on building centers that combine scientific excellence, AI-powered innovation and globally benchmarked laboratory standards with a patient-first approach."
Market Context
The expansion addresses growing demand for specialized fertility care across India driven by:
- Delayed parenthood
- Changing lifestyles
- Increasing awareness of assisted reproductive technologies